F.D.A. Rejects Closely Watched Lung Cancer Drug From China

Summary
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
Description from The New York Times.
Who is covering this
-
F.D.A. Rejects Closely Watched Lung Cancer Drug From China
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
Comments
Comments need JavaScript.